Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747108 · ClinicalTrials.gov registry record · NA
ForgIng New Paths to Prevent DIabeTes (FINDIT)
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 315
- Enrollment target
NCT02747108: Completed NA study, sponsored by VA Office of Research and Development.
NCT02747108 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 315 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02747108, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
Study Summary
This study will evaluate the effects of screening for type 2 diabetes mellitus (T2DM) and brief counseling about screening test results on weight and key health behaviors among Veterans with risk factors for T2DM. Study participants will be randomly assigned to one of two study groups: (1) Blood Test Group or (2) Brochure Group. Participants in the Blood Test Group will complete a blood test called hemoglobin A1c (HbA1c) which measures average blood sugar levels. Participants will receive brief counseling about the results from their primary care provider or someone authorized to speak on their behalf. Participants randomly selected for the Brochure Group will review a handout from the VA National Center for Health Promotion and Disease Prevention (NCP) on recommended screening tests and immunizations. All participants will be asked to complete a survey prior to study group assignment, immediately after a Primary Care appointment, 3 months after enrollment, and 12 months after enrollment.
Interventions
- BEHAVIORAL Blood Test Group Intervention
- BEHAVIORAL Brochure Group Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2015-12-02 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02747108
The ClinicalTrials.gov registry entry for NCT02747108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood Test Group Intervention is the first listed.
NCT02747108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02747108 about?
NCT02747108 is a clinical study titled "ForgIng New Paths to Prevent DIabeTes (FINDIT)". This study will evaluate the effects of screening for type 2 diabetes mellitus (T2DM) and brief counseling about screening test results on weight and key health behaviors among Veterans with risk factors for T2DM. Study participants will be randomly assigned to one of two study groups: (1) Blood Tes...
What is the current status of trial NCT02747108?
This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2015-12-02. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT02747108?
The interventions under investigation include: Blood Test Group Intervention (BEHAVIORAL), Brochure Group Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02747108?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.